475 related articles for article (PubMed ID: 33203568)
1. Gut microbiota, kynurenine pathway and mental disorders - Review.
Więdłocha M; Marcinowicz P; Janoska-Jaździk M; Szulc A
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 106():110145. PubMed ID: 33203568
[TBL] [Abstract][Full Text] [Related]
2. Involvement of the microbiota-gut-brain axis in chronic restraint stress: disturbances of the kynurenine metabolic pathway in both the gut and brain.
Deng Y; Zhou M; Wang J; Yao J; Yu J; Liu W; Wu L; Wang J; Gao R
Gut Microbes; 2021; 13(1):1-16. PubMed ID: 33535879
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiota-derived vitamins - underrated powers of a multipotent ally in psychiatric health and disease.
Rudzki L; Stone TW; Maes M; Misiak B; Samochowiec J; Szulc A
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Apr; 107():110240. PubMed ID: 33428888
[TBL] [Abstract][Full Text] [Related]
4. Kynurenine pathway metabolism and the microbiota-gut-brain axis.
Kennedy PJ; Cryan JF; Dinan TG; Clarke G
Neuropharmacology; 2017 Jan; 112(Pt B):399-412. PubMed ID: 27392632
[TBL] [Abstract][Full Text] [Related]
5. Focus on the essentials: tryptophan metabolism and the microbiome-gut-brain axis.
Gheorghe CE; Martin JA; Manriquez FV; Dinan TG; Cryan JF; Clarke G
Curr Opin Pharmacol; 2019 Oct; 48():137-145. PubMed ID: 31610413
[TBL] [Abstract][Full Text] [Related]
6. Kynurenines: Tryptophan's metabolites in exercise, inflammation, and mental health.
Cervenka I; Agudelo LZ; Ruas JL
Science; 2017 Jul; 357(6349):. PubMed ID: 28751584
[TBL] [Abstract][Full Text] [Related]
7. Gut microbiota: An intermediary between metabolic syndrome and cognitive deficits in schizophrenia.
Zeng C; Yang P; Cao T; Gu Y; Li N; Zhang B; Xu P; Liu Y; Luo Z; Cai H
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 106():110097. PubMed ID: 32916223
[TBL] [Abstract][Full Text] [Related]
8. Microbiota Alterations in Alzheimer's Disease: Involvement of the Kynurenine Pathway and Inflammation.
Garcez ML; Jacobs KR; Guillemin GJ
Neurotox Res; 2019 Aug; 36(2):424-436. PubMed ID: 31089885
[TBL] [Abstract][Full Text] [Related]
9. The Human Gut Microbiome as a Potential Factor in Autism Spectrum Disorder.
Alharthi A; Alhazmi S; Alburae N; Bahieldin A
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163286
[TBL] [Abstract][Full Text] [Related]
10. Tryptophan Metabolism and Gut-Brain Homeostasis.
Roth W; Zadeh K; Vekariya R; Ge Y; Mohamadzadeh M
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33804088
[TBL] [Abstract][Full Text] [Related]
11. Emerging role of gut microbiota in modulation of neuroinflammation and neurodegeneration with emphasis on Alzheimer's disease.
Goyal D; Ali SA; Singh RK
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 106():110112. PubMed ID: 32949638
[TBL] [Abstract][Full Text] [Related]
12. Bridging the Mind and Gut: Uncovering the Intricacies of Neurotransmitters, Neuropeptides, and their Influence on Neuropsychiatric Disorders.
Gupta S; Dinesh S; Sharma S
Cent Nerv Syst Agents Med Chem; 2024; 24(1):2-21. PubMed ID: 38265387
[TBL] [Abstract][Full Text] [Related]
13. Sex-related patterns of the gut-microbiota-brain axis in the neuropsychiatric conditions.
Manosso LM; Lin J; Carlessi AS; Recco KCC; Quevedo J; Gonçalves CL; Réus GZ
Brain Res Bull; 2021 Jun; 171():196-208. PubMed ID: 33838211
[TBL] [Abstract][Full Text] [Related]
14. Psychological comorbidity in gastrointestinal diseases: Update on the brain-gut-microbiome axis.
Person H; Keefer L
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Apr; 107():110209. PubMed ID: 33326819
[TBL] [Abstract][Full Text] [Related]
15. Emerging role of Gut-microbiota-brain axis in depression and therapeutic implication.
Evrensel A; Tarhan KN
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 106():110138. PubMed ID: 33075447
[TBL] [Abstract][Full Text] [Related]
16. The Brain-Gut-Microbiome System: Pathways and Implications for Autism Spectrum Disorder.
Chernikova MA; Flores GD; Kilroy E; Labus JS; Mayer EA; Aziz-Zadeh L
Nutrients; 2021 Dec; 13(12):. PubMed ID: 34960049
[TBL] [Abstract][Full Text] [Related]
17. A systematic review of microbiome changes and impact of probiotic supplementation in children and adolescents with neuropsychiatric disorders.
Ligezka AN; Sonmez AI; Corral-Frias MP; Golebiowski R; Lynch B; Croarkin PE; Romanowicz M
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jun; 108():110187. PubMed ID: 33271210
[TBL] [Abstract][Full Text] [Related]
18. Gut microbiota alteration and modulation in psychiatric disorders: Current evidence on fecal microbiota transplantation.
Settanni CR; Ianiro G; Bibbò S; Cammarota G; Gasbarrini A
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jul; 109():110258. PubMed ID: 33497754
[TBL] [Abstract][Full Text] [Related]
19. The Tryptophan and Kynurenine Pathway Involved in the Development of Immune-Related Diseases.
Tsuji A; Ikeda Y; Yoshikawa S; Taniguchi K; Sawamura H; Morikawa S; Nakashima M; Asai T; Matsuda S
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982811
[TBL] [Abstract][Full Text] [Related]
20. Major Depressive Disorder and gut microbiota - Association not causation. A scoping review.
Łoniewski I; Misera A; Skonieczna-Żydecka K; Kaczmarczyk M; Kaźmierczak-Siedlecka K; Misiak B; Marlicz W; Samochowiec J
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 106():110111. PubMed ID: 32976952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
